Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Rebecca Moore

Dr Rebecca Moore

Cognitive Assessment Tools – A Practical Guide: Which Option for Whom

Dr David Lim & Prof Richard Harvey

Dr David Lim & Prof Richard Harvey

Fireside Discussion – Chronic Sinusitis & Nasal Polys Management Update

A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Acne Scarring

Dr Mitchell Creinin MD

Dr Mitchell Creinin MD

Natural Estrogen, Contraception and Clot Risk

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024